MASS (908 Devices) Piotroski F-Score: 3 (As of Jun. 24, 2026) — Near Median


MASS 908 Devices Inc MASS
70 GF Score
Price $8.98
GF Value $6.91
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is 908 Devices Piotroski F-Score?

908 Devices MASS +2.87% 70 Piotroski F-Score is 3 as of Jun. 24, 2026, which is at its 10-year median of 3.00. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.91 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 805 Medical Devices & Instruments companies, 908 Devices ranks worse than 77.02% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

908 Devices has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for 908 Devices's Piotroski F-Score or its related term are showing as below:

MASS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 4
Current: 3

During the past 8 years, the highest Piotroski F-Score of 908 Devices was 4. The lowest was 2. And the median was 3.

908 Devices  (NAS:MASS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


908 Devices Piotroski F-Score Related Terms


908 Devices Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for 908 Devices's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

908 Devices Piotroski F-Score Chart

908 Devices Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 3.00 3.00 3.00 4.00 4.00

908 Devices Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 3.00 4.00 3.00

MASS vs ELMD, SI, CV: Piotroski F-Score Comparison

For the Medical Devices subindustry, 908 Devices's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


908 Devices Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where 908 Devices's Piotroski F-Score falls into.


MASS
70GF Score
908 Devices Inc MASS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -13.306 + -14.982 + 4.174 + -11.955 = $-36.07 Mil.
Cash Flow from Operations was -5.784 + -4.204 + 1.319 + 1.205 = $-7.46 Mil.
Revenue was 13.035 + 14.005 + 17.38 + 13.381 = $57.80 Mil.
Gross Profit was 6.373 + 7.355 + 9.154 + 6.882 = $29.76 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(196.027 + 191.701 + 190.873 + 190.071 + 186.695) / 5 = $191.0734 Mil.
Total Assets at the begining of this year (Mar25) was $196.03 Mil.
Long-Term Debt & Capital Lease Obligation was $3.77 Mil.
Total Current Assets was $142.01 Mil.
Total Current Liabilities was $39.66 Mil.
Net Income was -12.548 + -29.295 + -19.446 + 43.603 = $-17.69 Mil.

Revenue was 11.462 + 14.519 + 14.343 + 11.777 = $52.10 Mil.
Gross Profit was 6.162 + 7.778 + 6.673 + 5.541 = $26.15 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(189.791 + 208.774 + 178.283 + 159.476 + 196.027) / 5 = $186.4702 Mil.
Total Assets at the begining of last year (Mar24) was $189.79 Mil.
Long-Term Debt & Capital Lease Obligation was $2.71 Mil.
Total Current Assets was $149.00 Mil.
Total Current Liabilities was $19.56 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

908 Devices's current Net Income (TTM) was -36.07. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

908 Devices's current Cash Flow from Operations (TTM) was -7.46. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-36.069/196.027
=-0.18400016

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-17.686/189.791
=-0.09318672

908 Devices's return on assets of this year was -0.18400016. 908 Devices's return on assets of last year was -0.09318672. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

908 Devices's current Net Income (TTM) was -36.07. 908 Devices's current Cash Flow from Operations (TTM) was -7.46. ==> -7.46 > -36.07 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=3.766/191.0734
=0.0197097

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=2.714/186.4702
=0.0145546

908 Devices's gearing of this year was 0.0197097. 908 Devices's gearing of last year was 0.0145546. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=142.014/39.66
=3.58078669

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=149.004/19.561
=7.61740197

908 Devices's current ratio of this year was 3.58078669. 908 Devices's current ratio of last year was 7.61740197. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

908 Devices's number of shares in issue this year was 36.819. 908 Devices's number of shares in issue last year was 35.386. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=29.764/57.801
=0.51493919

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=26.154/52.101
=0.50198653

908 Devices's gross margin of this year was 0.51493919. 908 Devices's gross margin of last year was 0.50198653. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=57.801/196.027
=0.29486244

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=52.101/189.791
=0.27451776

908 Devices's asset turnover of this year was 0.29486244. 908 Devices's asset turnover of last year was 0.27451776. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

908 Devices has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
908 Devices (MASS) has a Piotroski F-Score of 3 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on 908 Devices and its competitors. This is near median its historical median of 3.00. Over the past decade, 908 Devices' Piotroski F-Score has ranged from 2.00 to 4.00. According to the industry distribution chart, 908 Devices ranks #620 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 77%.
Is 908 Devices' Piotroski F-Score too high?
908 Devices' current Piotroski F-Score of 3 is near median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 4.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. 908 Devices' value of 3 is 40% below this industry median. Based on the distribution chart, 908 Devices ranks #620 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Piotroski F-Score compare to ELMD and SI?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #620 out of 805 companies for Piotroski F-Score. This places 908 Devices in the lower half of its industry. The industry median Piotroski F-Score is 5.00. 908 Devices' value of 3 is 40% below this benchmark. Historically, 908 Devices' own Piotroski F-Score has ranged from 2.00 to 4.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, 908 Devices has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Piotroski F-Score is 3, which is near median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.91, compared to a current price of $8.98 — trading 30% above its estimated fair value. The current Piotroski F-Score is 3, which is near median its 10-year median of 3.00 and 40% below the Medical Devices & Instruments industry median of 5.00. 908 Devices' overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For 908 Devices (MASS), the current Piotroski F-Score is 3 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 908 Devices (MASS) Overvalued in 2026?

Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued. The current stock price of $8.98 is trading 30% above its estimated GF Value™ of $6.91. GuruFocus considers 908 Devices to be Modestly Overvalued.

Key valuation signals for MASS:

  • Piotroski F-Score: 3 (near median its 10-year median of 3.00)
  • GF Value™: $6.91 vs. price of $8.98 (30% above fair value)
  • GF Score™: 70/100 with 9 warning signs
  • Industry Position: 40% below the Medical Devices & Instruments median (#620 of 805)

No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


908 Devices Business Description

Address 44 3rd Avenue, Burlington, MA, USA, 01803
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score

Get the complete analysis for MASS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.98
Price
$6.91
GF Value